J Broom1, A Broom2, S Plage2, K Adams3, J J Post4. 1. Department of Medicine, Sunshine Coast Hospital and Health Service, Nambour, QLD, Australia; School of Medicine, The University of Queensland, QLD, Australia. Electronic address: jennifer.broom@health.qld.gov.au. 2. School of Social Sciences, The University of New South Wales, Sydney, NSW, Australia. 3. Department of Infectious Diseases, Hull and East Yorkshire NHS Trust, Kingston upon Hull, UK. 4. Department of Infectious Diseases, Prince of Wales Hospital and Prince of Wales Clinical School, The University of New South Wales, Sydney, NSW, Australia.
Abstract
BACKGROUND: The role of infectious diseases (ID) and clinical microbiology (CM) in hospital settings has expanded in response to increasing antimicrobial resistance, leading to widespread development of hospital antimicrobial stewardship (AMS) programmes, the majority of which include antibiotic approval systems. However, inappropriate antibiotic use in hospitals continues, suggesting potential disjunctions between technical advice and the logics of antibiotic use within hospitals. AIM: To examine the experiences of doctors in a UK hospital with respect to AMS guidance of antibiotic prescribing, and experiences of a verbal postprescription antibiotic approval process. METHODS: Twenty doctors in a teaching hospital in the UK participated in semi-structured interviews about their experiences of antibiotic use and governance. NVivo10 software was used to conduct a thematic content analysis systematically. FINDINGS: This study identified three key themes regarding doctors' relationships with ID/CM clinicians that shaped their antibiotic practices: (1) competing hierarchical influences limiting active consultation with ID/CM; (2) non-ID/CM consultants' sense of ownership over clinical decision-making and concerns about challenges to clinical autonomy; and (3) tensions between evidence-based practice and experiential-style learning. CONCLUSIONS: This study illustrates the importance of examining relations between ID/CM and non-ID/CM clinicians in the hospital context, indicating that AMS models that focus exclusively on delivering advice rather than managing interprofessional relationships may be limited in their capacity to optimize antibiotic use. AMS and, specifically, antibiotic approval systems would likely be more effective if they incorporated time and resources for fostering and maintaining professional relationships. Crown
BACKGROUND: The role of infectious diseases (ID) and clinical microbiology (CM) in hospital settings has expanded in response to increasing antimicrobial resistance, leading to widespread development of hospital antimicrobial stewardship (AMS) programmes, the majority of which include antibiotic approval systems. However, inappropriate antibiotic use in hospitals continues, suggesting potential disjunctions between technical advice and the logics of antibiotic use within hospitals. AIM: To examine the experiences of doctors in a UK hospital with respect to AMS guidance of antibiotic prescribing, and experiences of a verbal postprescription antibiotic approval process. METHODS: Twenty doctors in a teaching hospital in the UK participated in semi-structured interviews about their experiences of antibiotic use and governance. NVivo10 software was used to conduct a thematic content analysis systematically. FINDINGS: This study identified three key themes regarding doctors' relationships with ID/CM clinicians that shaped their antibiotic practices: (1) competing hierarchical influences limiting active consultation with ID/CM; (2) non-ID/CM consultants' sense of ownership over clinical decision-making and concerns about challenges to clinical autonomy; and (3) tensions between evidence-based practice and experiential-style learning. CONCLUSIONS: This study illustrates the importance of examining relations between ID/CM and non-ID/CM clinicians in the hospital context, indicating that AMS models that focus exclusively on delivering advice rather than managing interprofessional relationships may be limited in their capacity to optimize antibiotic use. AMS and, specifically, antibiotic approval systems would likely be more effective if they incorporated time and resources for fostering and maintaining professional relationships. Crown
Authors: Jacquelyn Mareau; Bruce Alexander; Jason Egge; Brett Heintz; Hiroyuki Suzuki; Daniel J Livorsi Journal: Open Forum Infect Dis Date: 2022-08-29 Impact factor: 4.423
Authors: Tamar F Barlam; Ellen Childs; Sarah A Zieminski; Tsega M Meshesha; Kathryn E Jones; Jorie M Butler; Laura J Damschroder; Matthew Bidwell Goetz; Karl Madaras-Kelly; Caitlin M Reardon; Matthew H Samore; Jincheng Shen; Edward Stenehjem; Yue Zhang; Mari-Lynn Drainoni Journal: Open Forum Infect Dis Date: 2020-06-15 Impact factor: 3.835
Authors: Michelle R Ananda-Rajah; Samuel Fitchett; Darshini Ayton; Anton Y Peleg; Shaun Fleming; Eliza Watson; Kelly Cairns; Trisha Peel Journal: Open Forum Infect Dis Date: 2020-05-21 Impact factor: 3.835
Authors: M Santillo; K Sivyer; A Krusche; F Mowbray; N Jones; T E A Peto; A S Walker; M J Llewelyn; L Yardley Journal: J Antimicrob Chemother Date: 2019-11-01 Impact factor: 5.790
Authors: Khezar Hayat; Meagen Rosenthal; Ali Hassan Gillani; Panpan Zhai; Muhammad Majid Aziz; Wenjing Ji; Jie Chang; Hao Hu; Yu Fang Journal: Int J Environ Res Public Health Date: 2019-05-05 Impact factor: 3.390
Authors: Gosha Wojcik; Nicola Ring; Corrienne McCulloch; Diane S Willis; Brian Williams; Kalliopi Kydonaki Journal: Arch Public Health Date: 2021-07-23